Skip to content
Politically.com Search all
Menu

Final rule 2026-10904

Medical Devices; Gastroenterology-Urology Devices; Classification of the Orally Ingested Transient Device for Constipation

The Food and Drug Administration (FDA) is classifying the orally ingested transient device for constipation into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the orally ingested transient device for constipation. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.

Source: FederalRegister.gov API v1Recently refreshed. Last successful refresh: 2026-07-31 22:49:02 UTC.

Source-supplied record

Document details

Document number
2026-10904
Published
Jun 1, 2026
Effective
Jun 1, 2026
Comments close
Not supplied
Federal Register citation
91 FR 32347

Docket identifiers

  • Docket No. FDA-2026-N-5196

CFR references

  • Title 21, part 876